A review of studies published during 1998 examining the treatment and management of benign prostatic obstruction

BJU International, Supplement

Volumn 85, Issue 1, 2000, Pages 46-53

  Frymann, R ^a   Cranston, D ^b   O'Boyle, P ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ANTIBIOTIC AGENT; FINASTERIDE; FUROSEMIDE; TAMSULOSIN; TERAZOSIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LASER SURGERY; MALE; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION;

HUMANS; MALE; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034059404     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Gallucci M, Puppo P, Perachino M et al. Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients. Eur Urol 1998; 33: 359-64
2. Kupeli S, Baltaci S, Soygur T, Aytac S, Yilmaz E, Budak M. A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH. Eur Urol 1998; 34: 15-8
3. Hammadeh MY, Madaan S, Singh M, Philp T. Two-year follow-up of a prospective randomised trial of electrovaporization versus resection of prostate. Eur Urol 1998; 34: 188-92
4. Hammadeh MY, Fowlis GA, Singh M, Philp T. Transurethral electrovaporization of the prostate - a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 1998; 81: 721-5
5. D'Ancona FCH, Francisca AEA, Witjes WPJ, Welling L, Debruyne FMJ, De La Rosette JJMCH. Transurethral resection of the prostate vs. high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81: 259-64
6. Bruskewitz R, Issa MM, Roehrborn CG et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998; 159: 1588-94
7. Jahnson S, Dalén M, Gustavsson G, Pedersen J. Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol 1998; 81: 276-81
8. Larson TR, Blute ML, Bruskewitz RC, Utz WJ. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998; 51: 731-42
9. Roehrborn CG, Preminger G, Newhall P, Womack S. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998; 51: 19-28
10. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC. 5-Year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs Cooperative Study. J Urol 1998; 160: 12-7
11. Gilling PJ, Cass CB, Malcolm A, Kabalin JN. Holmium laser resection of the prostate versus neodymium: yttrium-aluminium-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998; 51: 575-7
12. Ekman P. Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years, follow-up of the Scandinavian Open-Extension Study. Eur Urol 1998; 33: 312-7
13. Marberger MJ, on behalf of the PROWESS Study Group. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. Urology 1998; 51: 677-86
14. Lepor H, for the Tamsulosin Investigator Group. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Urology 1998; 51: 901-6
15. Debruyne FMJ, Jardin A, Colloi D et al. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. Eur Urol 1998; 34: 169-75
16. Kaplan SA, Reis RB, Cologna A, Te AE. Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms. Urology 1998; 52: 12-6
17. Lepor H, Williford WO, Barry MJ, Haakenson C, Jones K, for the Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. J Urol 1998; 160: 1358-67
18. Narayan P, Tewari A, and Members of United States 93-01 Study Group. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. J Urol 1998; 160: 1701-6
19. Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998; 81: 215-8
20. Scholz M, Luftenegger W, Harmuth H, Wolf D, Holtl W. Single-dose antibiotic prophylaxis in transurethral resection of the prostate: a prospective randomized trial. Br J Urol 1998; 81: 827-9
21. Djavan B, Shariat S, Schafer B, Marberger M. Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of prospective, randomized, single-blinded clinical trial. J Urol 1998; 160: 772-6
22. Hahn RG, Sandfeldt L, Nyman CR. Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of prostate. J Urol 1998; 160: 397-401
23. Zwergel U, Wullich B, Lindermeir U, Rohde V, Zwergel T. Long-term results following transurethral resection of the prostate. Eur Urol 1998; 33: 476-80
24. Gordon NSI. Catheter-free same day surgery transurethral resection of prostate. J Urol 1998; 160: 1709-12
25. Glass JM, Bdesha AS, Witherow R.O'N. Microwave thermotherapy: a long-term follow-up of 67 patients from a single centre. Br J Urol 1998; 81: 377-82
26. Eliasson T, Damber JE, Teriö H. Pressure-flow studies before and after transurethral microwave thermotherapy of benign prostatic hyperplasia using low- and high-energy protocols. Br J Urol 1998; 82: 513-9
27. Lau KO, Li MK, Foo KT. Long-term follow-up of transurethral microwave thermotherapy. Urology 1998; 52: 829-33
28. Stravodimos KG, Goldfischer ER, Klima WJ, Jabbour ME, Smith AD. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: a single-institution experience. Urology 1998; 51: 1008-12
29. Eliasson T, Damber JE. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy. J Urol 1998; 160: 777-82
30. Keijzers GBJM, Francisca EAE, D'Ancona FCH, Kiemeney LALM, Debruyne FMJ. de la Rosette JJMCH. Long-term results of lower energy transurethral microwave thermotherapy. J Urol 1998; 159: 1966-73
31. Larson TR, Collins JM, Corica A. Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patient with benign prostatic hyperplasia. J Urol 1998; 159: 258-64
32. Wagrell L, Schelin S, Bolmsjo M, Brudin L. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998; 159: 1583-7
33. Kahn SA, Alphonse P, Tewari A, Narayan P. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: The University of Florida experience. J Urol 1998; 160: 1695-700
34. Roehrborn CG, Issa MM, Bruskewitz RC, Narayan P. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter US study. Urology 1998; 51: 415-21
35. Neykov KG, Panchev P, Georgiev M. Late results after transurethral bladder neck incision. Eur Urol 1998; 33: 73-8
36. Cornford PA, Biyani CS, Powell CS. Transurethral incision of the prostate using holmium:YAG. A catheterless procedure. J Urol 1998; 159: 1229-31
37. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998; 33: 69-72
38. Mackey MJ, Chilton CP, Gilling PJ, Fraundorfer M, Cresswell MD. The results of holmium laser resection of the prostate. Br J Urol 1998; 81: 518-9
39. Arai Y, Okubo K, Okada T, Maekawa S, Aoki Y, Maeda H. Interstitial laser coagulation for management of benign prostatic hyperplasia: A Japanese experience. J Urol 1998; 159: 1961-65
40. Yakubu A, Barnes DG. Catheter-free endoscopic laser ablation of the prostate using a 1-size prostatic stent. J Urol 1998; 159: 1974-77
41. Uchida T, Muramoto M, Kyunou H, Koshiba K. Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology 1998; 52: 66-71
42. Makar AA, Thomas PJ, Fletcher MS, Harrison NW. Interstitial radiofrequency therapy of the prostate in the management of acute urinary retention. Br J Urol 1998; 81: 726-9
43. Desautel MG, Burney TL, Diaz PA, Austria A, Badlani GH. Outcome of Vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria. Urology 1998; 51: 1013-7
44. Gesenberg A, Sintermann R. Management of benign prostatic hyperplasia in high risk patients: long-term experience with Memotherm stent. J Urol 1998; 160: 72-6
45. Nickel JC for the Canadian PROSPECT Study Group. Placebo therapy of benign prostatic hyperplasia: a 25-month study. Br J Urol 1998; 81: 383-7
46. Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998; 51: 1003-7
47. Kirby RS. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men. Br J Urol 1998; 82: 373-9
48. Michel MC, Mehlburger L, Bressel HU, Schumacher H, Schafers RF, Goepel M. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does comorbidity alter tolerability? J Urol 1998; 160: 784-91
49. Bolmsjö M, Sturesson C, Wagrell L, Andersson-Engels S, Mattiasson A. Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998; 81: 811-6
50. Ronzoni G, De Vecchis M. Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck. Br J Urol 1998; 81: 830-3
51. Walden M, Dahlstrand C, Schäfer W, Pettersson S. How to select patients suitable for transurethral microwave thermotherapy: a systematic evaluation of potentially predictive variables. Br J Urol 1998; 81: 817-22
52. Jepsen JV, Leverson C, Bruskewitz RC. Variability in urinary flow rate and prostate volume; an investigation using the placebo arm of a drug trial. J Urol 1998; 160: 1689-94
53. Chakravarti A, MacDermott S. Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 1998; 81: 520-2
54. Akalin Z, Mungan N, Basar H, Aydoganil L, Cengiz T. Transurethral resection of the prostate and laser prostatectomy under local anesthesia. Eur Urol 1998; 33: 202-5
55. Vivien A, Lazard T, Rauss A, Laisne M, Bonnet F. Infection after transurethral resection of the prostate: variation among centers and correlation with a long-lasting surgical procedure. Eur Urol 1998; 33: 365-9
56. Horton R. Surgical Research or comic opera: questions, but few answers. Lancet 1996; 347: 984
57. McConnelll JD, Barry MJ, Bruskewitz RC et al. eds. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline. Rockville, Maryland: US Department of Health and Human Services, Agency for Health Care Policy and Research 1994
58. Fowler FJ, Wennberg JE, Timothy RP et al. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018-22
59. Neal DE. The National Prostatectomy Audit. Br J Urol 1997; 79: 69-75
60. Reynard JM, Peters TJ, Lim C, Abrams P. The value of multiple free flow studies in men with lower urinary tract symptoms. Br J Urol 1996; 77: 813-8
61. Hansen BJ, Mortensen S, Mensink HJA et al. and the Alfech Study Group. Comparison of the Danish prostatic symptom score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. Br J Urol 1998; 81: 62